Tag | Content |
---|
EnhancerAtlas ID | HS187-16072 |
Organism | Homo sapiens |
Tissue/cell | Th1 |
Coordinate | chr22:22170330-22172580 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Myod1 | MA0499.1 | chr22:22171630-22171643 | AGGGGCAGCTGCT | - | 6.18 | ZNF263 | MA0528.1 | chr22:22172524-22172545 | GGAGCAGCATGAGGATGAGGA | + | 6.35 |
|
| Number of super-enhancer constituents: 6 | ID | Coordinate | Tissue/cell |
SE_09367 | chr22:22167959-22175073 | CD14 | SE_11177 | chr22:22167098-22175290 | CD20 | SE_12977 | chr22:22169500-22172928 | CD34_Primary_RO01480 | SE_13591 | chr22:22168267-22174229 | CD34_Primary_RO01536 | SE_14291 | chr22:22169928-22173550 | CD34_Primary_RO01549 | SE_58780 | chr22:22161979-22223044 | Ly1 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr22 | 22170870 | 22171333 | chr22 | 22170364 | 22171810 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH22I021814 | chr22 | 22168522 | 22174688 |
|
Enhancer Sequence | AATACTCTTC CCTTGAGGAA CCCAAGATAT TGAGAGTGTC TAGTCATCTT AAATGAACAC 60 AACCTCAAGT CCCAGATGAA TTCTATCCTA AGACCCATAA ATTATGGAGA ATGGGAGGAC 120 ATTAAGGTCT GAAGTGAGCA CACCCATCTC AAGTCTCAAA ACAGATAGAT TCCTGCTATT 180 TGATAATAAA AGGAAATGAG ATTCCTATTT GATAATAACA GGAAATGAAC TATTGATATA 240 TGCAGCACAG ATGAATCTCA AGTAATTATG GTGAGTGAAG CCAGACCAAA AGAAATGTAT 300 TTCCATCTAT AGAAAATACA AAGTAATCCT GGGTTTACTT TGGATTTACC CCCAGGATTG 360 CCTGGGAATG GGAGGAAGAA GATTGCAAAT GGAAATGAGG TAACTTTTGG AGGCAATGAG 420 TATGTTCCTT ATCCTAATTG TGTTGATGGT TTCATAGGTG TATAATGTAT TAAAACTTAT 480 CCAACTTTAT ACTTTAAATG TGTGCAATAT TTTGTATATC AATTACTTCT TAGTAAAGCA 540 GTTAAAAAAA AAAAAAAAGA ACCAGGGTTC TTTGGCCACA TGATTCATTC CAGTGCTGGG 600 GCAATTGGGA TACAGATTCT AGAAGTGTAC CGATCAATAA ACGTAGAAGT CCATGAAATT 660 CTGAAGTAGA TTATTTAACA GATGTTTTAT GATTGCTTAG GGAAGGAAAG GGAACCAGCA 720 TGAGTCAATT ATGAACAAGT CATGCTAAAC TAGCTTTATT TCCTGTTTTG ATAGGGTTAC 780 CACAACAACA CGAAATGAAG ACAGAGTTCT GGTGAATTCA AGCCACGCTT GTCAAGAACT 840 TCCCATTTGT GAGGCTTCAT GTTAGGACTG GTGGCAAAAA CAAATAATGA TCCTGCTCTT 900 AAGAAACTTG CAATTTTGTG AGAGAAGGAG ACAGGAACAG AGAACATACT TTGCCTTTTA 960 TCACATTAAA GCACTTCTGA AACCCAAGGA GGAGCTGGGT TAACTTCAAA TACTAAGGGA 1020 AGGATTAAAA GAAGATGAGG CCCGCAAAAG CCTTATCCTG AAGGATGAGT AGGCTTCTGA 1080 CAGAAAAGCA AGACCGCAAA GAAAAGAAAG AGGAAACAGG AGGCGAGGTA AGAGACTGAG 1140 ACATCTGTGG TCACTGGCCA CTAACCCTCA CCCAGACATG CCCATGCCCA TGAGAGAAGG 1200 TTATTGGGGT CGGGGAAAAT GCTCCTCAGG TGCCCGGGAA TTCCCTGCAT CTGGAAAAGT 1260 GTAGTCTGTA CCCAGCAGGT GCACTTGAGG TGGTGGTCAA AGGGGCAGCT GCTTGCTGGC 1320 GTGTATTGCA CCTACATTGT GCAGGCAGGA GGCCACACAC GTGCTCAAGC TCACAACACA 1380 TGGATAGTGC TGTGGCTGGG AAGGGAAGAG CACTATGCTG AAGGTCTGCT CTGCCGGAAC 1440 TACTGACATA GAACTCTAAG GAGCCTGAGT ATTTTCTATT TGAACCCAAC CTTCCAGGTC 1500 ATTAAGAAGG TATATTAGGC CTGGTGTGGG CATGGTGATG CACGCTTGTA ATCCCAGCAC 1560 TTTGGGAGGG TGAGGAGGGC AGATCACTTG AATCCAGGTG TTCGAGATCA GTGTGGACAA 1620 CATGATGAAA CCCTGTCTCT ACAAAAAATA CAAAAATTAG CTGGGCATGG TGGCACTCGC 1680 CTGTAGTCCC AGCTATTTGG GGGACTAGGC AAGAGGATCA CTTGAGCCAG GGAGGTTGAG 1740 GCTGCAGTGA GCCATGATTG TGCCACTGCA CTCCAGCCTG GGTGACAAAG TGAGACCCTA 1800 TCTCAAAAAA AAAAAAAAGG AAAAGAAGGC ATATCTGTCA TGGCAGGAGG AGAGAGCAAA 1860 GTCTGCTTAA TGTTTCTTAG GTTGATTTTT TTTTTTTTTA ATGGTATGTA GGGCTCCATT 1920 TGTATTCTTG ACCTAGACCT TATAAACGTG AGAGGTGGGC CTGGGTCTGG GAGGTACAAA 1980 AAGAAGGTGG AGGTAAGGGA CAAAGATAGT TTTCAGCATC CTGATTTAAA AATCTAAGAA 2040 TGCCTGTCAG TGATTCAGAT GGAGGAGATG ACGGTTCCAT CCTTCCAGCA GCATCAGGAG 2100 AGAGATCAAG TTGGGAATTC TTAACAGAAG CCACAGTGAT TAGCACTCCT GCAGAGAGAG 2160 AATTTCAAGA AAAGAAGTCG GAAGACAGAA CTCAGGAGCA GCATGAGGAT GAGGAATCAG 2220 TTAAAGAAAG TGGAAAGAAA TGATAATGGA 2250
|